ALNOV:EPA
Novacyt SA
€ ०.४२
arrow_downward
-१.०६%(-०.००४५) 1D
नोभेम्बर ५, १५:०८:१६ GMT+१ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
€ ०.४२
High
€ ०.४३
Low
€ ०.४२
Mkt. cap
३.०४ करोड
Avg. vol.
१.९९ लाख
Volume
३२.०३ हजार
52-wk high
€ १.०४
52-wk low
€ ०.२९
EPS
-€ ०.३८
Shares outstanding
७.२६ करोड
No. of employees
२२८
Open
€ ०.४२
High
€ ०.४३
Low
€ ०.४२
Mkt. cap
३.०४ करोड
Avg. vol.
१.९९ लाख
Volume
३२.०३ हजार
52-wk high
€ १.०४
52-wk low
€ ०.२९
EPS
-€ ०.३८
Shares outstanding
७.२६ करोड
No. of employees
२२८
News stories
From web sources and news partners
Yahoo! Finance Canada
·
३१ मिनेट पहिले
NYSE Chair Sharon Bowen Earns Lifetime Achievement Award: NYSE Content Update
www.marketscreener.com
·
४१ मिनेट पहिले
Primech Holdings (Nasdaq: PMEC) Secures Approximately US$1.67 Million in Cleaning Services Contracts Running to 2029 Across Singapore’s Industrial and Residential Sectors
FinancialContent
·
४८ मिनेट पहिले
CRA (NASDAQ:CRAI) reports strong Q3 2026, full-year sales guidance is optimistic
Seeking Alpha
·
२४ मिनेट पहिले
S&P 500 Outlook: The 2027 Rally Depends On 2028 Earnings (SP500)
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA